In/FW
situ/FW
RT-PCR/NN
detection/NN
of/IN
Epstein-Barr/JJ
virus/NN
immediate-early/JJ
transcripts/NNS
in/IN
CD4+/JJ
and/CC
CD8+/JJ
T/NN
lymphocytes/NNS
./.

AIDS-related/JJ
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
-associated/JJ
T/NN
cell/NN
lymphomas/NNS
are/VBP
emerging/VBG
as/IN
a/DT
new/JJ
,/,
distinct/JJ
histopathological/JJ
entity/NN
./.
=====
The/DT
pathway/NN
whereby/WRB
EBV/NN
infects/VBZ
T/NN
cells/NNS
as/RB
well/RB
as/IN
the/DT
initial/JJ
EBV/NN
transcriptional/JJ
program/NN
in/IN
T/NN
cells/NNS
has/VBZ
not/RB
been/VBN
established/VBN
./.
=====
In/IN
order/NN
to/TO
shed/VB
light/NN
on/IN
the/DT
early/JJ
events/NNS
of/IN
the/DT
EBV/NN
infection/NN
of/IN
T/NN
cells/NNS
,/,
we/PRP
have/VBP
used/VBN
in/FW
situ/FW
reverse/JJ
transcription/NN
based/JJ
polymerase/NN
chain/NN
reaction/NN
(/(
RT-PCR/NN
)/)
to/TO
study/VB
the/DT
initial/JJ
EBV/NN
transcriptional/JJ
program/NN
in/IN
homogeneous/JJ
CD4+/JJ
and/CC
CD8+/JJ
lymphocytes/NNS
./.
=====
Following/VBG
EBV/NN
infection/NN
,/,
Epstein-Barr/JJ
nuclear/JJ
antigen/NN
(/(
EBNA/NN
)/)
expression/NN
could/MD
be/VB
detected/VBN
in/IN
T/NN
rosetting/NN
CD4+/JJ
and/CC
CD8+/JJ
T/NN
lymphocytes/NNS
./.
=====
Only/RB
a/DT
few/JJ
cells/NNS
showed/VBD
viral/JJ
capsid/NN
antigen/NN
(/(
VCA/NN
)/)
./.
=====
EBV/NN
immediate-early/JJ
gene/NN
transcripts/NNS
(/(
BZLF1/NN
,/,
BRLF1/NN
,/,
and/CC
BMLF1/NN
)/)
encoded/VBN
in/IN
the/DT
BamHI/NN
Z/NN
,/,
R/NN
,/,
and/CC
M/NN
fragments/NNS
could/MD
be/VB
detected/VBN
by/IN
in/FW
situ/FW
RT-PCR/NN
in/IN
the/DT
EBV/NN
producer/NN
cell/NN
line/NN
B95.8/NN
./.
=====
Both/CC
BZLF1/NN
and/CC
BRLF1/NN
immediate-early/JJ
transcripts/NNS
,/,
but/CC
not/RB
BMLF1/NN
transcript/NN
,/,
could/MD
be/VB
detected/VBN
in/IN
individual/JJ
CD4+/JJ
and/CC
CD8+/JJ
T/NN
cells/NNS
infected/VBN
with/IN
EBV/NN
./.
=====
Demonstration/NN
of/IN
EBV/NN
mRNA/NN
transcripts/NNS
encoding/VBG
immediate-early/JJ
transcriptional/JJ
transactivators/NNS
in/IN
EBV-infected/JJ
T/NN
cells/NNS
provides/VBZ
the/DT
first/JJ
evidence/NN
for/IN
a/DT
possible/JJ
mechanism/NN
whereby/IN
EBV/NN
could/MD
contribute/VB
to/TO
T/NN
cell/NN
proliferation/NN
and/CC
EBV-associated/JJ
T/NN
cell/NN
malignancies/NNS
./.